A phase 2 study has suggested that the glycoprotein (gp) IIb/IIIa blocker eptifibatide can be safely combined with a reduced dose of tPA in the treatment of acute ischemic stroke, and there was a ...

The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 ...

Stroke is one of the most serious medical emergencies in the world. It happens when blood flow to part of the brain is suddenly blocked or reduced. Without enough blood and oxygen, brain cells begin ...

A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment ...

FRESNO, Calif. (KFSN) -- Stroke is the third leading cause of death in the U.S. claiming the lives of more than 140,000 Americans each year. But many lives could be spared if treatment was given ...

Since 2022, the hospital has not been providing the life-saving, clot-dissolving TPA drug and instead sending stroke patients to PGI, losing precious time ...

Adding either argatroban or eptifibatide to thrombolytic therapy doesn't improve function following an ischemic stroke, results of new research show. "Ultimately, we found no benefit for either ...

Charleston, SC - Patients who have acute ischemic stroke on the weekend are more likely to receive aggressive treatment, including thrombolysis, than those patients who have an event during the week, ...

DALLAS, Feb. 1, 2024 — Compared with the standard clot-busting medication alteplase, the newer clot-buster tenecteplase may offer a safe, effective and simpler way to treat ischemic (clot-caused) ...

NEW YORK (Reuters Health) - There is never a good time to have a stroke, but a new study suggests that a person who suffers a stroke on a weekend is more apt to get clot-busting therapy on arrival at ...